Dronedarone versus sotalol in patients with atrial fibrillation: A systematic literature review and network meta-analysis.

The NMA findings indicate that, across all clinical trials and observational studies included, dronedarone compared with sotalol was associated with a lower risk of all-cause death, but with no difference in AF recurrence.